skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

As an industry, we spend tremendous amounts of time, money, and resources trying to enroll qualified participants in clinical trials. Despite our efforts, 7 out of 10 patients sent to a study site will screen fail. What’s worse, a quarter of all clinical studies close because they fail to meet enrollment targets — all while viable recruiting partners are often left on the sidelines.

Patient Recruitment


That’s why we decided to rethink the traditional patient recruiting model to make it better for everyone: sponsors, partners, and, most importantly, patients.

Citeline Connect connects the dots between patients and trials.

Citeline Connect is an industry-first patient referral collective. We use data, technology, and teamwork to better connect sponsors with a collective of recruitment partners to accelerate clinical trial enrollment in a pay-for-performance model.


Behind it all is the experience, knowledge, and industry savvy that make us the world’s leading provider of clinical trials intelligence in the competitive pharmaceutical industry.


Study Sponsors

Open up more opportunities for patients to discover your trial

Choose collaboration over competition

Citeline Connect brings together key stakeholders — sponsors, recruitment partners, healthcare organizations, and patient/disease advocacy groups — to better match patients to clinical trials. This enables sponsors to:

  • Broaden  your recruitment funnel
  • Optimize and accelerate enrollment
  • Pay for performance


Minimize risk, maximize success

Approximately 85% of clinical trials fail to recruit enough patients. The odds are stacked against you, so it makes sense to boost your chances with Citeline Connect. Our patient recruitment collective features vetted recruitment partners who refer patients to your trials through the platform. With Citeline Connect, you also control who sees your eligibility criteria and site information, protecting your competitive edge.

  • Don’t limit yourself to one or two recruitment partners
  • Set your own referral fees for each trial
  • Pay only per patient referred or randomized

Reduce site burden


Easing your administrative burden and meeting enrollment objectives do not have to be mutually exclusive

  • Fast-track ideal candidates with built-in patient prescreeners
  • Track the source of each patient referral
  • Automate compensation to referral partners

Request a demo


Recruitment Partners

Earn revenue by accessing more recruiting opportunities

More recruitment opportunities. Less stress.

As a patient recruitment partner, you know that winning sponsor business isn’t easy. You spend a significant amount of time and resources building relationships, responding to RFPs, getting vetted, signing paperwork — all just to win one paid recruitment opportunity. Then the work begins all over again. Citeline Connect offers a more efficient approach:

  • Go through the vetting process one time only
  • Sign one contract with Citeline Connect, vs. individual sponsors
  • Avoid complex system integrations with our easily accessible portal

Sponsor access, granted

You have patients who are interested in participating in clinical research. But without sponsor access, you lack the incentive, data, or technology you need to make a meaningful connection between a patient and a trial.

  • Enjoy a steady stream of opportunities with complete trial information
  • Choose the trials that best fit your patient populations
  • Use sponsor’s built-in patient prescreeners to produce quality referrals

Don’t chase patients. Or payments.

Imagine a world where you never have to ask another referral, “Did you enroll in that trial?” A world where you never hire a call center, send manual emails, or pick up a phone for follow-up.

  • See the status of all your referrals at a glance
  • Trust built-in verification processes of referrals
  • Automatic payment upon patient enrollment

Citeline Connect is simply another channel to do more of what you already do — and do it better.


Request a demo

Related products


Sitetrove: Clinical trial site & investigator identification

Over 450,000 investigators from 170,000+ sites in 180+ countries, all with clinical trial experience, at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove.

Key benefits:

  • Investigator Tiering
  • Patient Count Data
  • Dynamic/Exportable Visualizations

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

  • Curated by experts
  • Clinical trial landscape view
  • Ask-the-Analyst™
pharma intelligence pharma banner

Pharmaprojects: track pharma R&D

The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.

Key benefits:

  • Curated by experts
  • Drug R&D landscape
  • Historical trends

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700
  • Australia        : +61 2 8705 6907

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: